Matthew Muller

Matthew Muller

PhD Candidate, Biomedical Engineering
Ruggles & Berger Laboratories
NYU Tandon School of Engineering & NYU Langone Health
Matthew.Muller@nyulangone.org

I am a PhD candidate in Biomedical Engineering at New York University, co-mentored by Dr. Kelly Ruggles and Dr. Jeffrey Berger at the NYU Tandon School of Engineering and NYU Langone Health. My research sits at the intersection of multi-omic computational biology and cardiovascular medicine, with a focus on discovering translational biomarkers and molecular disease subtypes in high-risk patient populations.

I use blood-based multi-omic profiling to identify and explain residual cardiovascular risk, the events that still occur in patients receiving the best available care. In the ISCHEMIA trials biorepository, I integrate genomics, transcriptomics, methylomics, and proteomics to define molecular subtypes of chronic coronary disease with divergent outcomes. I also develop platelet-based RNA and protein scores (PRESS, TIPS, PROSPER) that flag patients whose risk is driven by platelet reactivity. My work includes 30+ publications, 10+ as first author, and two U.S. provisional patents.

Prior to my PhD, I spent four years working with Dr. Jonathan Lindner at the Knight Cardiovascular Institute at OHSU investigating therapeutic and diagnostic ultrasound, characterizing shear-dependent vasoactive pathways and VWF-mediated thromboinflammatory mechanisms in peripheral artery disease and aortic stenosis.

My research program spans two complementary areas:

Cardiovascular multi-omics. I lead computational analyses of the ISCHEMIA trials biorepository, integrating whole-genome sequencing, whole-blood transcriptomics, DNA methylomics, and proteomics to identify molecularly distinct subtypes of chronic coronary disease with differential clinical outcomes. This work has defined vulnerable epigenomic and transcriptomic subtypes and cardiometabolic subtypes with divergent risk profiles, alongside a characterization of clonal hematopoiesis in this population.

Platelet biology & biomarker discovery. I develop platelet transcriptomic and proteomic scoring tools—PRESS (Platelet Reactivity ExpreSsion Score), TIPS (platelet Transcriptomic signature of thrombInflammation and Platelet reactivity Score), and PROSPER (PROtein Signature of PlatelEt Reactivity)—validated across patients with peripheral artery disease, systemic lupus erythematosus, and chronic coronary disease. These tools predict cardiovascular events prospectively and are the basis of two U.S. provisional patents.

2023–2026
PhD, Biomedical Engineering
NYU Tandon School of Engineering, New York, NY
2022–2023
MS, Biomedical Informatics
NYU Grossman School of Medicine, New York, NY
2014–2018
BA, Chemistry
Reed College, Portland, OR
Cardiovascular Multi-Omics
  • Muller M, Cornwell MG, Rajkumar S, Chen Z, et al. "Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary disease." Nature Communications, 2026.
  • Muller M, Rajkumar S, Sastourne P, Cornwell MG, et al. "Cardiometabolic subtypes define divergent risk profiles within chronic coronary disease." JCI Insight, 2026. Accepted
  • Muller M, Liu R, Shah F, Hu J, et al. "Clonal Hematopoiesis of Indeterminate Potential in Chronic Coronary Disease: A Report From the ISCHEMIA Trials Biorepository." Circulation: Genomic and Precision Medicine, 2025.
Platelet Biology & Biomarker Discovery
  • Muller M, Hamo CE, Xia Y, Newman JD, et al. "A circulating protein signature linking platelet reactivity to cardiovascular risk." JCI Insight, 2026. Accepted
  • Muller MA, Luttrell-Williams E, Bash H, Cornwell MG, et al. "Platelet Gene Expression in Systemic Lupus Erythematosus and Cardiovascular Health." JACC: Basic to Translational Science, 2025.
  • Berger JS, Cornwell MG, Xia Y, Muller MA, et al. "A Platelet Reactivity ExpreSsion Score derived from patients with peripheral artery disease predicts cardiovascular risk." Nature Communications, 2024.
Therapeutic Ultrasound & Vascular Biology
  • Ozawa K, Muller MA, Varlamov O, Hagen MW, et al. "Reduced Proteolytic Cleavage of von Willebrand Factor Leads to Aortic Valve Stenosis and Load-Dependent Ventricular Remodeling." JACC: Basic to Translational Science, 2022.
  • Muller MA, Ozawa K, Hodovan J, Hagen MW, et al. "Treatment of Limb Ischemia with Conducted Effects of Catheter-Based Endovascular Ultrasound." Ultrasound in Medicine & Biology, 2021.
  • Muller MA, Xie A, Qi Y, Zhao Y, et al. "Regional and Conducted Vascular Effects of Endovascular Ultrasound Catheters." Ultrasound in Medicine & Biology, 2020.
  • Ozawa K, Muller MA, Varlamov O, Tavori H, et al. "Proteolysis of Von Willebrand Factor Influences Inflammatory Endothelial Activation and Vascular Compliance in Atherosclerosis." JACC: Basic to Translational Science, 2020.
2025
"A Circulating Protein Signature of Platelet Reactivity Predicts Cardiovascular Risk." U.S. Prov. App. No. 63/912,729. With J.S. Berger, T.J. Barrett. Assignee: New York University.
2025
"A Platelet Transcriptomic Signature of Thromboinflammation Predicts Cardiovascular Risk." U.S. Prov. App. No. 63/944,739. With J.S. Berger, T.J. Barrett. Assignee: New York University.
2022
ASE Foundation Early Career Investigator Award — American Society of Echocardiography Scientific Sessions, Seattle, WA
2022
Alan S. Pearlman Research Award — American Society of Echocardiography Scientific Sessions, Seattle, WA
Bioinformatics
RNA-seq, scRNA-seq, proteomics, methylomics, metabolomics, WGS/WES; multi-omic integration
Data Science
ML/DL for biological and clinical data; scikit-learn, TensorFlow, PyTorch, Docker, Git
Languages
Python, R, Bash — advanced; SQL, MATLAB — intermediate
Wet Lab
Ultrasound, histology, cryotome, GC-MS/MS, NMR, microscopy, PCR